Isofol Medical AB (OSTO:ISOFOL) E10: kr-1.62 (As of Mar. 2026)


OSTO:ISOFOL Isofol Medical AB OSTO:ISOFOL
30 GF Score
Price kr0.71
! 2 Warning Signs
View Full Analysis

What is Isofol Medical AB E10?

Isofol Medical AB OSTO:ISOFOL -0.42% 30 E10 is kr-1.62 as of Mar. 2026. GuruFocus rates OSTO:ISOFOL with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Isofol Medical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was kr-0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-1.62 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-27), Isofol Medical AB's current stock price is kr0.707. Isofol Medical AB's E10 for the quarter that ended in Mar. 2026 was kr-1.62. Isofol Medical AB's Shiller PE Ratio of today is .


Isofol Medical AB  (OSTO:ISOFOL) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Isofol Medical AB E10 Related Terms


Isofol Medical AB E10 Historical Data

* Premium members only.

The historical data trend for Isofol Medical AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Isofol Medical AB E10 Chart

Isofol Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -1.66

Isofol Medical AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -1.66 -1.62

OSTO:ISOFOL vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, Isofol Medical AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Isofol Medical AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Isofol Medical AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Isofol Medical AB's Shiller PE Ratio falls into.


OSTO:ISOFOL
30GF Score
Isofol Medical AB OSTO:ISOFOL
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Isofol Medical AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Isofol Medical AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.05/133.3862*133.3862
=-0.050

Current CPI (Mar. 2026) = 133.3862.

Isofol Medical AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.319 101.019 -0.421
201609 -0.271 101.138 -0.357
201612 -0.955 102.022 -1.249
201703 -0.394 102.022 -0.515
201706 -0.215 102.752 -0.279
201709 -0.364 103.279 -0.470
201712 -0.464 103.793 -0.596
201803 -0.314 103.962 -0.403
201806 -0.265 104.875 -0.337
201809 -0.269 105.679 -0.340
201812 -0.454 105.912 -0.572
201903 -0.419 105.886 -0.528
201906 -0.750 106.742 -0.937
201909 -0.910 107.214 -1.132
201912 -0.902 107.766 -1.116
202003 -1.209 106.563 -1.513
202006 -0.914 107.498 -1.134
202009 -0.250 107.635 -0.310
202012 -0.455 108.296 -0.560
202103 -0.354 108.360 -0.436
202106 -0.422 108.928 -0.517
202109 -0.281 110.338 -0.340
202112 -0.325 112.486 -0.385
202203 -0.264 114.825 -0.307
202206 -0.290 118.384 -0.327
202209 -0.176 122.296 -0.192
202212 -0.141 126.365 -0.149
202303 -0.079 127.042 -0.083
202306 -0.044 129.407 -0.045
202309 -0.035 130.224 -0.036
202312 -0.044 131.912 -0.044
202403 -0.044 132.205 -0.044
202406 -0.070 132.716 -0.070
202409 -0.070 132.304 -0.071
202412 -0.080 132.987 -0.080
202503 -0.080 132.825 -0.080
202506 -0.090 133.699 -0.090
202509 -0.050 133.482 -0.050
202512 -0.050 133.386 -0.050
202603 -0.050 133.386 -0.050

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of kr-1.62 mean?
Isofol Medical AB (OSTO:ISOFOL) has a E10 of kr-1.62 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Isofol Medical AB and its competitors.
Is Isofol Medical AB's E10 too high?
Isofol Medical AB's current E10 is kr-1.62. Overall, Isofol Medical AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Isofol Medical AB's E10 compare to VRTX and REGN?
Isofol Medical AB's E10 of kr-1.62 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Isofol Medical AB and its competitors. Isofol Medical AB's current E10 is kr-1.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Isofol Medical AB stock overvalued right now?
Isofol Medical AB (OSTO:ISOFOL) has a current E10 of kr-1.62. The current E10 is kr-1.62. Isofol Medical AB's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Isofol Medical AB (OSTO:ISOFOL), the current E10 is kr-1.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Isofol Medical AB Business Description

Address Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46
Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.
30GF Score

Get the complete analysis for OSTO:ISOFOL

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.71
Price